Bought on morning breakout. This biotech stock had all sorts of news regarding its Hepatitis C trial drug. Several financial news outlets reported that the FDA lifted a hold on the Hep C drug being developed by this company. This caused the stock to breakout over several days. It always seems like a publicly traded company's stocks shoot up whenever the FDA lifts a hold or gives approval for a new drug being developed by the said firm.